Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Cash & Equivalents (2020 - 2025)

KORU Medical Systems has reported Cash & Equivalents over the past 11 years, most recently at $8.9 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $8.9 million for Q4 2025, down 7.4% from a year ago — trailing twelve months through Dec 2025 was $8.9 million (down 7.4% YoY), and the annual figure for FY2025 was $8.9 million, down 7.4%.
  • Cash & Equivalents for Q4 2025 was $8.9 million at KORU Medical Systems, up from $8.5 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for KRMD hit a ceiling of $26.8 million in Q1 2021 and a floor of $8.1 million in Q2 2025.
  • Median Cash & Equivalents over the past 5 years was $11.6 million (2023), compared with a mean of $15.0 million.
  • Biggest five-year swings in Cash & Equivalents: surged 260.47% in 2021 and later crashed 45.85% in 2023.
  • KORU Medical Systems' Cash & Equivalents stood at $25.3 million in 2021, then crashed by 31.29% to $17.4 million in 2022, then plummeted by 34.04% to $11.5 million in 2023, then decreased by 16.56% to $9.6 million in 2024, then decreased by 7.4% to $8.9 million in 2025.
  • The last three reported values for Cash & Equivalents were $8.9 million (Q4 2025), $8.5 million (Q3 2025), and $8.1 million (Q2 2025) per Business Quant data.